Ligan, Baby Boy .

HRN: 24-32-48  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/29/2024
AMPICILLIN 500MG (VIAL)
02/29/2024
03/06/2024
IVT
150mg
Q12
Prophylaxis; Sepsis
Waiting Final Action 
02/29/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/29/2024
03/06/2024
IVT
30mg
Q24
Prophylaxis; Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: